Due to be ready for launch in 2025, the experiments will be supervised by astronauts on board for up to six months before returning to Earth for the results to be analysed.
D(MG)2, led by the Institute of Cancer Research, received £1.2 million to look at diffuse midline glioma; the second most common type of “primary high grade” brain tumour in children that has, so far, been impossible to cure due to the amount of different cell types it contains.
Stay connected to UKNIP via Google News
ENJOYED THIS STORY? Choose UKNIP as a 'Preferred Source' on Google News for quick access to the news you value.
